<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02887326</url>
  </required_header>
  <id_info>
    <org_study_id>AUH-3828</org_study_id>
    <nct_id>NCT02887326</nct_id>
  </id_info>
  <brief_title>Keratoconus - Biomarkers and Questionnaire</brief_title>
  <official_title>Keratoconus - Biomarkers and Questionnaire</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The biomarker study adds to our previous study on biomarkers in tear fluid. In this study the
      investigators examine wether the biomarker levels are in correlation with the disease level
      and duration of disease.

      The questionnaire study focuses on the patients perspective. With a validated questionnaire
      fore keratoconus patient it examine the patients self.-evaluated visual challenges and
      quality of life
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Protein levels in tear fluid, saliva and blood(plasma)</measure>
    <time_frame>fall 2018</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ranch analysis of questionnaire</measure>
    <time_frame>fall 2018</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">287</enrollment>
  <condition>Keratoconus</condition>
  <arm_group>
    <arm_group_label>age 15-25 years</arm_group_label>
    <description>Ophthalmic examination, VA measure, contrast vision, pentacam measurement, Tear fluid, saliva and blood samples</description>
  </arm_group>
  <arm_group>
    <arm_group_label>age 25-35 years</arm_group_label>
    <description>Ophthalmic examination, VA measure, contrast vision, pentacam measurement, Tear fluid, saliva and blood samples</description>
  </arm_group>
  <arm_group>
    <arm_group_label>age 35-45 year</arm_group_label>
    <description>Ophthalmic examination, VA measure, contrast vision, pentacam measurement, Tear fluid, saliva and blood samples</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&gt; age 45 year</arm_group_label>
    <description>Ophthalmic examination, VA measure, contrast vision, pentacam measurement, Tear fluid, saliva and blood samples</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tear fluid, saliva and blood.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with keratoconus residing in the Central Denmark Region
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Keratoconus residint in the Central Denmark Region

        Exclusion Criteria:

          -  Other eye diseases

          -  Ocular traumas.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>August 29, 2016</study_first_submitted>
  <study_first_submitted_qc>September 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2016</study_first_posted>
  <last_update_submitted>October 12, 2018</last_update_submitted>
  <last_update_submitted_qc>October 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

